3 completed, 1 withdrawn. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
Follow Venipuncture: new trials by email Literature Review of Venipuncture trials Research Report on Venipuncture
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treg Therapy in Subclinical Inflammation in Kidney Transplantation Polyclonal Regulatory T Cells, Everolimus, Tacrolimus - Kidney Transplant, Adult Living Donor Kidney Transplant Recipients | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 32 | 2016-09-20 | 2026-09-24 |
| Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy Cabazitaxel, Neulasta, CT Scan - Urothelial Carcinoma | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 14 | 2012-02-16 | 2025-05-04 |
| A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia VEGF Trap, Bone marrow biopsy, bone marrow aspiration - Leukemia | Phase 2 | Withdrawn | Vanderbilt-Ingram Cancer Center | 2007-03-01 | 2013-04-02 | |
| Phase I/II Thymus Transplantation With Immunosuppression #950 Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly | Phase 1 / Phase 2 | Completed | Sumitomo Pharma Switzerland GmbH | 14 | 2005-12-19 | 2022-03-25 |
Carcinoma, Transitional Cell (1) · DiGeorge Syndrome (1) · Hypocalcemia (1) · Hypoparathyroidism (1) · Immunologic Deficiency Syndromes (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Thymic aplasia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Sumitomo Pharma Switzerland GmbH (1) · Vanderbilt-Ingram Cancer Center (1)
United States (3)
Flavio Vincenti, MD (1) · Jean Hoffman-Censits, MD (1) · M. Louise Markert, MD, PhD (1) · Sindhu Chandran, MD (1) · Stephen Strickland, MD (1)
PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 23607606
K12HD043494 (1), P30CA068485 (1), R01AI047040 (1), R01AI054843 (1)